JOSEPH ARGENTA: Open Payments
NPI 1104150234 · ELKIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,029 in 149 payments from 18 companies in 2025. Trend: 2023 $4,274 · 2024 $2,660 · 2025 $3,029
Food & beverage: $2,851Education: $178
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $382 |
| ABBVIE INC. | 24 | $372 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $286 |
| Gilead Sciences, Inc. | 12 | $280 |
| Ardelyx, Inc. | 15 | $261 |
| Phathom Pharmaceuticals, Inc. | 14 | $247 |
| Madrigal Pharmaceuticals | 10 | $221 |
| Aimmune Therapeutics, Inc. | 9 | $197 |
| Regeneron Healthcare Solutions, Inc. | 6 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $163 |
Products named: TREMFYA, DUPIXENT, XIFAXAN, IBSRELA, VOQUEZNA, REZDIFFRA, ZENPEP, RINVOQ.
Industry payments across NC — which companies pay providers there.
